WCM Investment Management CA acquired a new stake in shares of Iqvia Holdings Inc (NYSE:IQV) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 818,926 shares of the medical research company’s stock, valued at approximately $80,173,000. Iqvia accounts for approximately 0.9% of WCM Investment Management CA’s holdings, making the stock its 16th largest position.
Other large investors have also bought and sold shares of the company. Winslow Evans & Crocker Inc. bought a new stake in Iqvia during the fourth quarter valued at $123,000. IFP Advisors Inc bought a new stake in Iqvia during the fourth quarter valued at $200,000. Livforsakringsbolaget Skandia Omsesidigt bought a new stake in Iqvia during the fourth quarter valued at $209,000. Atria Investments LLC bought a new stake in Iqvia during the fourth quarter valued at $218,000. Finally, First Quadrant L P CA bought a new stake in Iqvia during the fourth quarter valued at $221,000. 95.79% of the stock is owned by institutional investors.
Several equities research analysts recently issued reports on the company. Zacks Investment Research lowered Iqvia from a “buy” rating to a “hold” rating in a research note on Friday, November 3rd. Barclays lifted their price objective on Iqvia from $100.00 to $120.00 and gave the company an “overweight” rating in a research note on Friday, October 27th. Stifel Nicolaus raised Iqvia from a “hold” rating to a “buy” rating and lifted their price objective for the company from $92.00 to $128.00 in a research note on Friday, October 27th. Morgan Stanley lifted their price objective on Iqvia from $96.00 to $121.00 and gave the company an “overweight” rating in a research note on Thursday, November 9th. Finally, Mizuho set a $97.00 price objective on Iqvia and gave the company a “hold” rating in a research note on Wednesday, January 24th. Seven research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $109.71.
In other news, Director John Connaughton sold 1,163,191 shares of Iqvia stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $102.00, for a total value of $118,645,482.00. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of Iqvia stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $102.00, for a total value of $764,776,314.00. The disclosure for this sale can be found here. Insiders have sold 8,727,078 shares of company stock worth $890,124,079 in the last 90 days. Company insiders own 6.40% of the company’s stock.
WARNING: “818,926 Shares in Iqvia Holdings Inc (IQV) Acquired by WCM Investment Management CA” was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://sportsperspectives.com/2018/02/08/818926-shares-in-iqvia-holdings-inc-iqv-acquired-by-wcm-investment-management-ca.html.
Iqvia Company Profile
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.